These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

876 related items for PubMed ID: 10087017

  • 1. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 2. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 3. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M, Hirth-Dietrich C, Stasch JP.
    Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
    [Abstract] [Full Text] [Related]

  • 4. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
    [Abstract] [Full Text] [Related]

  • 5. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 6. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM, Burrell LM, Kladis A, Campbell DJ.
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
    [Abstract] [Full Text] [Related]

  • 8. Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction.
    Dumoulin MJ, Adam A, Rouleau JL, Gosselin H, Lamontagne D.
    Can J Physiol Pharmacol; 2003 Jul; 81(7):740-6. PubMed ID: 12897822
    [Abstract] [Full Text] [Related]

  • 9. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 12. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 13. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF.
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
    Kozlovski VI, Lomnicka M, Jakubowski A, Chlopicki S.
    Pharmacol Rep; 2007 Feb; 59(4):421-7. PubMed ID: 17901571
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM, Burrell LM, Kladis A, Campbell DJ.
    J Card Fail; 1997 Mar; 3(1):41-52. PubMed ID: 9110254
    [Abstract] [Full Text] [Related]

  • 17. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM, Belloni AS, Guidolin D, Sticchi D, Nussdorfer GG, Pessina AC, Rossi GP.
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [Abstract] [Full Text] [Related]

  • 18. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ, Kladis A, Duncan AM.
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE, Ghai RD, Trapani AJ, Odorico LM, Dardik BN, De Lombaert S, Lappe RW, Fink CA.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [Abstract] [Full Text] [Related]

  • 20. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.